Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP309687.RAk4BCHhuunQgOeSuzhg8guTN596rVg0dnjpUeZ9Bw1-U130_assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309687.RAk4BCHhuunQgOeSuzhg8guTN596rVg0dnjpUeZ9Bw1-U130_provenance.
• NP583207.RA5p-RHMpu6nipsTvisCKIkOepMC0m9Msv262J0Eu9RwI130_assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583207.RA5p-RHMpu6nipsTvisCKIkOepMC0m9Msv262J0Eu9RwI130_provenance.
• NP535690.RASFNp8BAkq1dO-F_kQa7kXM0MAdoR1pm0YRtoHBvKb9U130_assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535690.RASFNp8BAkq1dO-F_kQa7kXM0MAdoR1pm0YRtoHBvKb9U130_provenance.
• NP855947.RAzvhBA035AqcdsSh5Bj3CalF6XgpmBRpGV-EaqiUcYG8130_assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855947.RAzvhBA035AqcdsSh5Bj3CalF6XgpmBRpGV-EaqiUcYG8130_provenance.
• assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416849.RAbAOQmialEVMQ3R0jB1Tv7YTjggPUBBEa1YktV9CAF9Q130_provenance.
• NP535689.RArLhKjzumBs1xD1GQNkdbN_oMbtcYvHBGD4jnsMXrOVQ130_assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535689.RArLhKjzumBs1xD1GQNkdbN_oMbtcYvHBGD4jnsMXrOVQ130_provenance.
• NP416847.RAqBPuBWUQlJPlgbhdkN4sPMBZ1vD-eRrjV2MlhnrRg9o130_assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416847.RAqBPuBWUQlJPlgbhdkN4sPMBZ1vD-eRrjV2MlhnrRg9o130_provenance.
• NP416846.RA3zo37-pa60u8YW-jfUlQpUvHgWNG_j3SKes28UH0VXU130_assertion description "[Oncofetal fibronectin (onfFN) and galectin-3 (Gale-3) have been proposed as possible tools for the preoperative diagnosis of thyroid carcinomas, based on the finding that the expression of both onfFN and Gale-3 are significantly increased in papillary and anaplastic carcinomas, compared to normal thyroid tissues and follicular adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416846.RA3zo37-pa60u8YW-jfUlQpUvHgWNG_j3SKes28UH0VXU130_provenance.